Russia says its Ebola vaccine 'effective' in initial tests

February 15, 2016

Russia's health minister said Monday that an Ebola vaccine developed by the country over the last 15 months had shown encouraging results and would undergo further testing in West Africa.

"Phases one and two of testing were managed in Russia with volunteers and showed that the was very effective," minister Veronika Skovortsova told reporters in Geneva.

Skovortsova said the vaccine GamEvac-Combi, developed at a government vaccine research institute, would now be put to additional tests in Guinea.

The West African countries of Guinea, Liberia and Sierra Leone have been hardest-hit by the worst-ever Ebola outbreak which has killed more than 11,300 people since December 2013.

The Russian minister made the comments ahead of a meeting Tuesday with the UN's World Health Organization chief Margaret Chan.

The WHO is hoping to study the Russian findings before giving an opinion on the new vaccine.

WHO spokeswoman Fadela Chaib told AFP in an email that the UN agency was aware that "Russian regulatory authorities had approved an anti-Ebola vaccine.

"The WHO secretariat is actively hoping for the possibility to study the data," regarding the performance of the vaccine, she added.

According to the Russian official, the preliminary testing showed limited side effects in isolated cases, including headaches and slight body temperature rises.

Russian officials at the briefing who led the testing said the sequential injections led to surge in antibody production among the trial subjects.

So far no approved vaccine or treatment for Ebola exists and the WHO has authorised the fast-track development of drugs.

Explore further: Putin claims Russia has developed Ebola vaccine

Related Stories

Ebola vaccine shows 'promising' results: WHO

July 31, 2015

Preliminary results of tests on an Ebola vaccine to be published later Friday in British science magazine The Lancet have shown "promising" results, World Health Organization Director-General Margaret Chan said.

WHO yet to take Canada's experimental Ebola vaccine

October 9, 2014

Doses of a prototype Ebola vaccine developed by Canada remain in the country even though they were offered to the World Health Organization nearly two months ago, the health minister said Thursday.

Recommended for you

Zika virus infection alters human and viral RNA

October 20, 2016

Researchers at University of California San Diego School of Medicine have discovered that Zika virus infection leads to modifications of both viral and human genetic material. These modifications—chemical tags known as ...

Food-poisoning bacteria may be behind Crohn's disease

October 19, 2016

People who retain a particular bacterium in their gut after a bout of food poisoning may be at an increased risk of developing Crohn's disease later in life, according to a new study led by researchers at McMaster University.

Neurodevelopmental model of Zika may provide rapid answers

October 19, 2016

A newly published study from researchers working in collaboration with the Regenerative Bioscience Center at the University of Georgia demonstrates fetal death and brain damage in early chick embryos similar to microcephaly—a ...

Scientists uncover new facets of Zika-related birth defects

October 17, 2016

In a study that could one day help eliminate the tragic birth defects caused by Zika virus, scientists from the Florida campus of The Scripps Research Institute (TSRI) have elucidated how the virus attacks the brains of newborns, ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.